Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NAT2 |
| Upstream (Parents) |
|---|
| (<<) A1CF → NAT2 |
| (<<) ADH6 → NAT2 |
| (<<) CYP4F2 → NAT2 |
| Downstream (Children) |
|---|
| NAT2 → NR1I2 (>>) |
| NAT2 → AP4S1 (>>) |
| NAT2 → TBC1D2B (>>) |
| NAT2 → GSDMB (>>) |
| NAT2 → ORAI2 (>>) |
| NAT2 → GPR182 (>>) |
| NAT2 → CYP4F12 (>>) |
| NAT2 → FABP1 (>>) |
| NAT2 → CDHR5 (>>) |
| NAT2 → CACNG5 (>>) |
| NAT2 → NCS1 (>>) |
| NAT2 → RAB3B (>>) |
